You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 137 No. 5, May 2001 TABLE OF CONTENTS
  Archives
  •  Online Features
  Study
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (72)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Hemangiomas
 •Alert me on articles by topic

A Unique Microvascular Phenotype Shared by Juvenile Hemangiomas and Human Placenta

Paula E. North, MD, PhD; Milton Waner, MD; Adam Mizeracki; Robert E. Mrak, MD, PhD; Richard Nicholas, MD; Jay Kincannon, MD; James Y. Suen, MD; Martin C. Mihm, Jr, MD

Arch Dermatol. 2001;137:559-570.

Background  Juvenile hemangiomas are common, benign tumors, distinctive for their perinatal presentation, rapid growth during the first year of life, and subsequent involution. We recently reported that endothelia of hemangiomas highly express GLUT1, a glucose transporter normally restricted to endothelia with blood-tissue barrier function, as in brain and placenta.

Objective  To investigate possible further similarities between hemangioma and placental vessels.

Design  In a retrospective study of a variety of vascular tumors and anomalies, we assessed lesional immunoreactivities for the placenta-associated vascular antigens Fc{gamma}RII, Lewis Y antigen (LeY), merosin, and GLUT1.

Setting  A university-affiliated pediatric hospital.

Main Outcome Measure  Immunoreactivities scored for each antigen were summarized according to lesional type, compared with those of normal skin, brain, and placenta, and correlated with patient age, sex, and lesional location.

Results  All of 66 hemangiomas (patients aged 22 days to 7 years) showed intense immunoreactivity for Fc{gamma}RII, merosin, LeY, and GLUT1. No immunoreactivities for these markers were seen in any of 26 vascular malformations, 4 granulation tissue specimens, 13 pyogenic granulomas, or in the tumor vasculature of 6 malignant tumors of nonvascular origin. Microvascular immunoreactivity for all 4 markers was observed in placental chorionic villi, but was absent in microvessels of normal skin and subcutis. Brain microvessels expressed only GLUT1 and merosin.

Conclusions  A distinct constellation of tissue-specific markers is uniquely coexpressed by hemangiomas and placental microvessels. These findings imply a unique relationship between hemangioma and the placenta and suggest new hypotheses concerning the origin of these tumors.


From the Departments of Pathology (Drs North and Mrak and Mr Mizeracki), Otolaryngology (Drs Waner and Suen and Mr Mizeracki), Orthopedic Surgery (Dr Nicholas), and Dermatology (Dr Kincannon), University of Arkansas for Medical Sciences and Arkansas Children's Hospital, and the Department of Veterans Affairs Medical Center, Little Rock (Dr Mrak); and the Department of Pathology, Harvard University Medical School, and Massachusetts General Hospital, Boston (Dr Mihm).


RELATED ARTICLE

Archives of Dermatology Reader's Choice: Continuing Medical Education
Arch Dermatol. 2001;137(5):680-681.
FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Multiple Cutaneous Infantile Hemangiomas Associated With Hepatic Angiosarcoma: Case Report and Review of the Literature
Nord et al.
Pediatrics 2006;118:e907-e913.
ABSTRACT | FULL TEXT  

Patterns of Infantile Hemangiomas: New Clues to Hemangioma Pathogenesis and Embryonic Facial Development
Haggstrom et al.
Pediatrics 2006;117:698-703.
ABSTRACT | FULL TEXT  

Myeloid Cells in Infantile Hemangioma
Ritter et al.
Am. J. Pathol. 2006;168:621-628.
ABSTRACT | FULL TEXT  

Evidence by molecular profiling for a placental origin of infantile hemangioma
Barnes et al.
Proc. Natl. Acad. Sci. USA 2005;102:19097-19102.
ABSTRACT | FULL TEXT  

Hemangiomas of Infancy: Clinical and Biological Characteristics
Smolinski and Yan
CLIN PEDIATR 2005;44:747-766.
ABSTRACT  

Current Knowledge of the Pathogenesis of Infantile Hemangiomas
Phung et al.
Arch Facial Plast Surg 2005;7:319-321.
ABSTRACT | FULL TEXT  

Multifocal Lymphangioendotheliomatosis With Thrombocytopenia: A Newly Recognized Clinicopathological Entity
North et al.
Arch Dermatol 2004;140:599-606.
ABSTRACT | FULL TEXT  

Case 13-2004 - A Newborn Girl with a Large Cutaneous Lesion, Thrombocytopenia, and Anemia
Mulliken et al.
NEJM 2004;350:1764-1775.
FULL TEXT  

The Nonrandom Distribution of Facial Hemangiomas
Waner et al.
Arch Dermatol 2003;139:869-875.
ABSTRACT | FULL TEXT  

Type 3 Iodothyronine Deiodinase Is Highly Expressed in the Human Uteroplacental Unit and in Fetal Epithelium
Huang et al.
J. Clin. Endocrinol. Metab. 2003;88:1384-1388.
ABSTRACT | FULL TEXT  

Retinal neovascular markers in retinopathy of prematurity: aetiological implications
North et al.
Br. J. Ophthalmol. 2003;87:275-278.
ABSTRACT | FULL TEXT  

Infantile Hemangioma: Clinical Resolution With 5% Imiquimod Cream
Martinez et al.
Arch Dermatol 2002;138:881-884.
FULL TEXT  

From the Cover: Insulin-like growth factor 2 and potential regulators of hemangioma growth and involution identified by large-scale expression analysis
Ritter et al.
Proc. Natl. Acad. Sci. USA 2002;99:7455-7460.
ABSTRACT | FULL TEXT  

Congenital Nonprogressive Hemangioma: A Distinct Clinicopathologic Entity Unlike Infantile Hemangioma
North et al.
Arch Dermatol 2001;137:1607-1620.
ABSTRACT | FULL TEXT  

Are Juvenile Hemangiomas Related to Maternal Placentas?
Journal Watch Dermatology 2001;2001:1-1.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.